Your browser doesn't support javascript.
loading
Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.
Napoletano, C; Rughetti, A; Landi, R; Pinto, D; Bellati, F; Rahimi, H; Spinelli, G P; Pauselli, S; Sale, P; Dolo, V; De Lorenzo, F; Tomao, F; Benedetti-Panici, P; Frati, L; Nuti, M.
Affiliation
  • Napoletano C; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Int J Immunopathol Pharmacol ; 22(3): 647-58, 2009.
Article in En | MEDLINE | ID: mdl-19822081
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Breast Neoplasms / Lymphocyte Activation / Immunotherapy, Adoptive / Receptor, ErbB-2 / CD8-Positive T-Lymphocytes / Transport Vesicles / Antigens, Neoplasm Limits: Female / Humans Language: En Journal: Int J Immunopathol Pharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / PATOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Breast Neoplasms / Lymphocyte Activation / Immunotherapy, Adoptive / Receptor, ErbB-2 / CD8-Positive T-Lymphocytes / Transport Vesicles / Antigens, Neoplasm Limits: Female / Humans Language: En Journal: Int J Immunopathol Pharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / PATOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication: